- Home
- Clinical Trials
Vitiligo Study Pukekohe FB
Vitiligo Study
Pukekohe Auckland
Living with Vitiligo, characterised by white patches on skin, can be hugely challenging and better treatment options are needed for those affected.
Momentum Clinical Research are evaluating the effectiveness of an investigational treatment designed to inhibit the immune response that causes vitiligo patches.
Your participation in this study could not only benefit you but also help make a difference in the lives of others with this condition.
Description
What to expect
Study details
Ages
18 - 75 years old
Duration
30 weeks and includes 11 scheduled clinic visits
Compensation
Eligible participants will be reimbursed
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 75 years.
- Have been diagnosed with non-segmental vitiligo for at least 3 months
- Have vitiligo patches on 4% to 50% of the body - This can be assessed by our study doctors for you.
- Have some vitiligo patches on the face.
Additional criteria will be discussed with you.
Locations
Description
Vitiligo is a long-term skin condition characterised by flat white spots or patches on the skin which may start small and enlarge and change shape over time. The hair from the skin may also become white.
Vitiligo is believed to be an autoimmune condition in which the immune system mistakenly attacks and destroys the cells responsible for producing melanin, the pigment that gives skin its colour.
Vitiligo can significantly affect a person's emotional and psychological well-being. The condition is not painful and does not have significant health consequences, but the psychological impact of the changing appearance of the skin can be substantial for those affected.
What to expect
This study is evaluating the effectiveness of an investigational treatment containing an antibody that is delivered intravenously to inhibit the specific immune responses that are involved in the destruction of pigment producing cells.
If you are interested in participating or learning more about the study, please register your details. Your participation could not only benefit you but also help make a difference in the lives of others suffering from this condition.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- Under the Privacy Act 2020, you may ask if we hold personal information on you, you may request access to the information we hold, and you may ask for correction of your personal information. You can ask to be removed from our contact list at any time.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.